Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
NCT Number: NCT03334500
Men with a history of prostate cancer may be in this study. Subjects recommended for a prostatectomy or oligometastectomy will undergo PET/CT imaging using a novel radiotracer [18F]FTT to evaluate PARP-1 activity in known or suspected sites of primary or metastatic disease. Imaging will be compared with pathology results, including additional research assays when possible.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Early Phase 1
Philadelphia, Pennsylvania, 19104, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Fluorine-18 labeled FluorThanatrace [18F]FTT can be synthesized with high specific activity so the quantity of mass injected with the radiopharmaceutical is < 10 μg.
Other names: 18F-FTT
Poly(ADP-ribose) polymerase (PARP) is a family of enzymes involved in base excision repair (the repair of DNA single-strand breaks) and alternative end joining (repair of DNA double-strand breaks). The molecular basis of PARP1 inhibitor function may depend on the dual roles of PARP1 as a modulator of gene transcription in addition to DNA damage repair 3.
Other names: PARP 1
Time frame: 3 years
Abramson Cancer Center at Penn Medicine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02923180
Genital Diseases, Genital Diseases, Male
Baltimore, Maryland, United States
View Trial DetailsNCT03181867
Cancer Of Prostate, Genital Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT04557449
Adenocarcinoma, Adenocarcinoma of Lung
Los Angeles, California, United States
View Trial DetailsNCT00977457
Genital Diseases, Genital Diseases, Male
Duarte, California, United States
View Trial Details